News & Articles
25
Selected Filters:
Product News
Breast cancer cell line array from AMSBIO
Product News
Patient-derived human primary cancer cells
Product News
Cell-free nucleic acid extraction
Industry News
Safeguarding organoids through lockdown
Internationally renowned Hans Clevers Lab reports using AMSBIO’s CELLBANKER reagent to freeze down their organoids ahead of the COVID-19 spring lockdown
Product News
AMSBIO launch recombinant monoclonal antibody development service
The platform can directly isolate IgG genes from B cells of immunized animals
Product News
AMSBIO announces an optimized medium for expansion of mesenchymal stem cells
StemFit for mesenchymal stem cells (MSC) is the latest addition to the StemFit family of stem cell media
Product News
AMSBIO launches powerful human iPSC-derived cells, kits & services for high-throughput experiments
This proprietary technology allows for rapid, reproducible differentiation of human iPSC-derived excitatory, GABAergic, dopaminergic and cholinergic neurons
Product News
Tailored solutions for exosome-related research
Product News
Differentiation of Human iPS and ES Cells
Industry News
Screening for novel inhibitors of SARS-CoV-2 infection
New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin
Product News
New range of SARS-CoV-2 Spike protein products
Industry News
Identifying targets for development of COVID-19 drugs and vaccines
AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines
Product News
AMSBIO announces Skeletal Muscle Differentiation kit
Differentiate human pluripotent stem cells to muscle myotubes
Industry News
AMSBIO announces custom chimeric antigen receptor T cell (CAR-T) service
These CAR-T cell therapies are designed to be used in the treatment of hematological malignancies